nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—Mesalazine—PPARG—psoriasis	0.00563	0.661	CrCbGaD
Methyldopa—Epinephrine—TNF—psoriasis	0.00288	0.338	CrCbGaD
Methyldopa—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.0016	0.00162	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.0016	0.00162	CcSEcCtD
Methyldopa—Angiopathy—Cyclosporine—psoriasis	0.0016	0.00161	CcSEcCtD
Methyldopa—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.00159	0.00161	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.00159	0.00161	CcSEcCtD
Methyldopa—Bradycardia—Hydrocortisone—psoriasis	0.00159	0.00161	CcSEcCtD
Methyldopa—Mediastinal disorder—Cyclosporine—psoriasis	0.00159	0.0016	CcSEcCtD
Methyldopa—Constipation—Hydroxyurea—psoriasis	0.00158	0.00159	CcSEcCtD
Methyldopa—Nausea—Calcitriol—psoriasis	0.00157	0.00158	CcSEcCtD
Methyldopa—Angiopathy—Mycophenolate mofetil—psoriasis	0.00156	0.00157	CcSEcCtD
Methyldopa—Dizziness—Acitretin—psoriasis	0.00155	0.00157	CcSEcCtD
Methyldopa—Dizziness—Fluocinolone Acetonide—psoriasis	0.00155	0.00156	CcSEcCtD
Methyldopa—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.00155	0.00156	CcSEcCtD
Methyldopa—Oedema—Mycophenolic acid—psoriasis	0.00155	0.00156	CcSEcCtD
Methyldopa—Mental disorder—Cyclosporine—psoriasis	0.00154	0.00156	CcSEcCtD
Methyldopa—Connective tissue disorder—Hydrocortisone—psoriasis	0.00154	0.00155	CcSEcCtD
Methyldopa—Infection—Mycophenolic acid—psoriasis	0.00154	0.00155	CcSEcCtD
Methyldopa—Weight increased—Dexamethasone—psoriasis	0.00152	0.00153	CcSEcCtD
Methyldopa—Weight increased—Betamethasone—psoriasis	0.00152	0.00153	CcSEcCtD
Methyldopa—Nervous system disorder—Mycophenolic acid—psoriasis	0.00152	0.00153	CcSEcCtD
Methyldopa—Thrombocytopenia—Mycophenolic acid—psoriasis	0.00151	0.00153	CcSEcCtD
Methyldopa—Flatulence—Cyclosporine—psoriasis	0.00151	0.00152	CcSEcCtD
Methyldopa—Mental disorder—Mycophenolate mofetil—psoriasis	0.0015	0.00152	CcSEcCtD
Methyldopa—Skin disorder—Mycophenolic acid—psoriasis	0.0015	0.00151	CcSEcCtD
Methyldopa—Bradycardia—Triamcinolone—psoriasis	0.0015	0.00151	CcSEcCtD
Methyldopa—Vomiting—Acitretin—psoriasis	0.00149	0.00151	CcSEcCtD
Methyldopa—Vomiting—Fluocinolone Acetonide—psoriasis	0.00149	0.0015	CcSEcCtD
Methyldopa—Rash—Acitretin—psoriasis	0.00148	0.0015	CcSEcCtD
Methyldopa—Dermatitis—Acitretin—psoriasis	0.00148	0.00149	CcSEcCtD
Methyldopa—Rash—Fluocinolone Acetonide—psoriasis	0.00148	0.00149	CcSEcCtD
Methyldopa—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00148	0.00149	CcSEcCtD
Methyldopa—Flatulence—Mycophenolate mofetil—psoriasis	0.00147	0.00149	CcSEcCtD
Methyldopa—Headache—Acitretin—psoriasis	0.00147	0.00149	CcSEcCtD
Methyldopa—Headache—Fluocinolone Acetonide—psoriasis	0.00147	0.00148	CcSEcCtD
Methyldopa—Abdominal distension—Prednisone—psoriasis	0.00146	0.00148	CcSEcCtD
Methyldopa—Body temperature increased—Hydroxyurea—psoriasis	0.00146	0.00147	CcSEcCtD
Methyldopa—Pancreatitis—Prednisone—psoriasis	0.00143	0.00144	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.00141	0.00142	CcSEcCtD
Methyldopa—Nausea—Acitretin—psoriasis	0.0014	0.00141	CcSEcCtD
Methyldopa—Nausea—Fluocinolone Acetonide—psoriasis	0.00139	0.0014	CcSEcCtD
Methyldopa—Paraesthesia—Mycophenolic acid—psoriasis	0.00139	0.0014	CcSEcCtD
Methyldopa—Leukopenia—Cyclosporine—psoriasis	0.00137	0.00138	CcSEcCtD
Methyldopa—Mental disorder—Hydrocortisone—psoriasis	0.00137	0.00138	CcSEcCtD
Methyldopa—Bradycardia—Dexamethasone—psoriasis	0.00136	0.00137	CcSEcCtD
Methyldopa—Bradycardia—Betamethasone—psoriasis	0.00136	0.00137	CcSEcCtD
Methyldopa—Hypersensitivity—Hydroxyurea—psoriasis	0.00136	0.00137	CcSEcCtD
Methyldopa—Erectile dysfunction—Prednisone—psoriasis	0.00134	0.00135	CcSEcCtD
Methyldopa—Leukopenia—Mycophenolate mofetil—psoriasis	0.00134	0.00135	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.00133	0.00135	CcSEcCtD
Methyldopa—Asthenia—Hydroxyurea—psoriasis	0.00132	0.00134	CcSEcCtD
Methyldopa—Weight increased—Prednisone—psoriasis	0.00132	0.00133	CcSEcCtD
Methyldopa—Constipation—Mycophenolic acid—psoriasis	0.00132	0.00133	CcSEcCtD
Methyldopa—Arthralgia—Cyclosporine—psoriasis	0.0013	0.00132	CcSEcCtD
Methyldopa—Myalgia—Cyclosporine—psoriasis	0.0013	0.00132	CcSEcCtD
Methyldopa—Liver function test abnormal—Methotrexate—psoriasis	0.0013	0.00131	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.0013	0.00131	CcSEcCtD
Methyldopa—Arthralgia—Mycophenolate mofetil—psoriasis	0.00127	0.00128	CcSEcCtD
Methyldopa—Myalgia—Mycophenolate mofetil—psoriasis	0.00127	0.00128	CcSEcCtD
Methyldopa—Breast disorder—Methotrexate—psoriasis	0.00127	0.00128	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Methotrexate—psoriasis	0.00127	0.00128	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.00126	0.00127	CcSEcCtD
Methyldopa—Diarrhoea—Hydroxyurea—psoriasis	0.00126	0.00127	CcSEcCtD
Methyldopa—Oedema—Cyclosporine—psoriasis	0.00125	0.00126	CcSEcCtD
Methyldopa—Infection—Cyclosporine—psoriasis	0.00124	0.00125	CcSEcCtD
Methyldopa—Nervous system disorder—Cyclosporine—psoriasis	0.00123	0.00124	CcSEcCtD
Methyldopa—Thrombocytopenia—Cyclosporine—psoriasis	0.00122	0.00123	CcSEcCtD
Methyldopa—Body temperature increased—Mycophenolic acid—psoriasis	0.00122	0.00123	CcSEcCtD
Methyldopa—Dizziness—Hydroxyurea—psoriasis	0.00122	0.00123	CcSEcCtD
Methyldopa—Oedema—Mycophenolate mofetil—psoriasis	0.00122	0.00123	CcSEcCtD
Methyldopa—Skin disorder—Cyclosporine—psoriasis	0.00121	0.00123	CcSEcCtD
Methyldopa—Angiopathy—Betamethasone—psoriasis	0.00121	0.00122	CcSEcCtD
Methyldopa—Angiopathy—Dexamethasone—psoriasis	0.00121	0.00122	CcSEcCtD
Methyldopa—Infection—Mycophenolate mofetil—psoriasis	0.00121	0.00122	CcSEcCtD
Methyldopa—Eosinophilia—Methotrexate—psoriasis	0.0012	0.00121	CcSEcCtD
Methyldopa—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.0012	0.00121	CcSEcCtD
Methyldopa—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.00119	0.0012	CcSEcCtD
Methyldopa—Pancreatitis—Methotrexate—psoriasis	0.00119	0.0012	CcSEcCtD
Methyldopa—Skin disorder—Mycophenolate mofetil—psoriasis	0.00118	0.0012	CcSEcCtD
Methyldopa—Bradycardia—Prednisone—psoriasis	0.00118	0.0012	CcSEcCtD
Methyldopa—Vomiting—Hydroxyurea—psoriasis	0.00117	0.00118	CcSEcCtD
Methyldopa—Rash—Hydroxyurea—psoriasis	0.00116	0.00117	CcSEcCtD
Methyldopa—Dermatitis—Hydroxyurea—psoriasis	0.00116	0.00117	CcSEcCtD
Methyldopa—Myalgia—Hydrocortisone—psoriasis	0.00116	0.00117	CcSEcCtD
Methyldopa—Headache—Hydroxyurea—psoriasis	0.00116	0.00117	CcSEcCtD
Methyldopa—Pancytopenia—Methotrexate—psoriasis	0.00115	0.00116	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.00115	0.00116	CcSEcCtD
Methyldopa—Connective tissue disorder—Prednisone—psoriasis	0.00114	0.00115	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.00114	0.00115	CcSEcCtD
Methyldopa—Oedema—Prednisolone—psoriasis	0.00114	0.00115	CcSEcCtD
Methyldopa—Paraesthesia—Cyclosporine—psoriasis	0.00112	0.00113	CcSEcCtD
Methyldopa—Erectile dysfunction—Methotrexate—psoriasis	0.00112	0.00113	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.00111	0.00112	CcSEcCtD
Methyldopa—Oedema—Hydrocortisone—psoriasis	0.00111	0.00112	CcSEcCtD
Methyldopa—Asthenia—Mycophenolic acid—psoriasis	0.00111	0.00112	CcSEcCtD
Methyldopa—Infection—Hydrocortisone—psoriasis	0.0011	0.00111	CcSEcCtD
Methyldopa—Nausea—Hydroxyurea—psoriasis	0.0011	0.00111	CcSEcCtD
Methyldopa—Paraesthesia—Mycophenolate mofetil—psoriasis	0.0011	0.0011	CcSEcCtD
Methyldopa—Myalgia—Triamcinolone—psoriasis	0.00109	0.0011	CcSEcCtD
Methyldopa—Nervous system disorder—Hydrocortisone—psoriasis	0.00109	0.0011	CcSEcCtD
Methyldopa—Infestation NOS—Methotrexate—psoriasis	0.00108	0.00109	CcSEcCtD
Methyldopa—Infestation—Methotrexate—psoriasis	0.00108	0.00109	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Cyclosporine—psoriasis	0.00108	0.00109	CcSEcCtD
Methyldopa—Skin disorder—Hydrocortisone—psoriasis	0.00108	0.00109	CcSEcCtD
Methyldopa—Constipation—Cyclosporine—psoriasis	0.00107	0.00108	CcSEcCtD
Methyldopa—Diarrhoea—Mycophenolic acid—psoriasis	0.00106	0.00107	CcSEcCtD
Methyldopa—Angiopathy—Prednisone—psoriasis	0.00106	0.00107	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.00105	0.00106	CcSEcCtD
Methyldopa—Oedema—Triamcinolone—psoriasis	0.00105	0.00106	CcSEcCtD
Methyldopa—Constipation—Mycophenolate mofetil—psoriasis	0.00104	0.00105	CcSEcCtD
Methyldopa—Infection—Triamcinolone—psoriasis	0.00104	0.00105	CcSEcCtD
Methyldopa—Hepatobiliary disease—Methotrexate—psoriasis	0.00102	0.00103	CcSEcCtD
Methyldopa—Dizziness—Mycophenolic acid—psoriasis	0.00102	0.00103	CcSEcCtD
Methyldopa—Paraesthesia—Prednisolone—psoriasis	0.00102	0.00103	CcSEcCtD
Methyldopa—Mental disorder—Prednisone—psoriasis	0.00102	0.00103	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00101	0.00102	CcSEcCtD
Methyldopa—Agranulocytosis—Methotrexate—psoriasis	0.00101	0.00102	CcSEcCtD
Methyldopa—Paraesthesia—Hydrocortisone—psoriasis	0.000998	0.00101	CcSEcCtD
Methyldopa—Myalgia—Dexamethasone—psoriasis	0.000991	0.000999	CcSEcCtD
Methyldopa—Myalgia—Betamethasone—psoriasis	0.000991	0.000999	CcSEcCtD
Methyldopa—Body temperature increased—Cyclosporine—psoriasis	0.000989	0.000997	CcSEcCtD
Methyldopa—Vomiting—Mycophenolic acid—psoriasis	0.000983	0.000991	CcSEcCtD
Methyldopa—Rash—Mycophenolic acid—psoriasis	0.000975	0.000983	CcSEcCtD
Methyldopa—Dermatitis—Mycophenolic acid—psoriasis	0.000974	0.000982	CcSEcCtD
Methyldopa—Hepatitis—Methotrexate—psoriasis	0.000973	0.000981	CcSEcCtD
Methyldopa—Headache—Mycophenolic acid—psoriasis	0.000968	0.000977	CcSEcCtD
Methyldopa—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000964	0.000973	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00096	0.000968	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000953	0.000962	CcSEcCtD
Methyldopa—Oedema—Dexamethasone—psoriasis	0.00095	0.000958	CcSEcCtD
Methyldopa—Oedema—Betamethasone—psoriasis	0.00095	0.000958	CcSEcCtD
Methyldopa—Infection—Dexamethasone—psoriasis	0.000943	0.000951	CcSEcCtD
Methyldopa—Infection—Betamethasone—psoriasis	0.000943	0.000951	CcSEcCtD
Methyldopa—Paraesthesia—Triamcinolone—psoriasis	0.00094	0.000948	CcSEcCtD
Methyldopa—Nervous system disorder—Dexamethasone—psoriasis	0.000931	0.000939	CcSEcCtD
Methyldopa—Nervous system disorder—Betamethasone—psoriasis	0.000931	0.000939	CcSEcCtD
Methyldopa—Thrombocytopenia—Betamethasone—psoriasis	0.00093	0.000938	CcSEcCtD
Methyldopa—Thrombocytopenia—Dexamethasone—psoriasis	0.00093	0.000938	CcSEcCtD
Methyldopa—Hypersensitivity—Cyclosporine—psoriasis	0.000921	0.000929	CcSEcCtD
Methyldopa—Nausea—Mycophenolic acid—psoriasis	0.000918	0.000926	CcSEcCtD
Methyldopa—Cardiac disorder—Methotrexate—psoriasis	0.000903	0.000911	CcSEcCtD
Methyldopa—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000899	0.000907	CcSEcCtD
Methyldopa—Asthenia—Cyclosporine—psoriasis	0.000897	0.000905	CcSEcCtD
Methyldopa—Angiopathy—Methotrexate—psoriasis	0.000883	0.00089	CcSEcCtD
Methyldopa—Body temperature increased—Hydrocortisone—psoriasis	0.000879	0.000886	CcSEcCtD
Methyldopa—Mediastinal disorder—Methotrexate—psoriasis	0.000877	0.000884	CcSEcCtD
Methyldopa—Asthenia—Mycophenolate mofetil—psoriasis	0.000875	0.000883	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000865	0.000873	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000865	0.000873	CcSEcCtD
Methyldopa—Arthralgia—Prednisone—psoriasis	0.000863	0.00087	CcSEcCtD
Methyldopa—Myalgia—Prednisone—psoriasis	0.000863	0.00087	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000857	0.000864	CcSEcCtD
Methyldopa—Diarrhoea—Cyclosporine—psoriasis	0.000856	0.000863	CcSEcCtD
Methyldopa—Paraesthesia—Dexamethasone—psoriasis	0.000853	0.00086	CcSEcCtD
Methyldopa—Paraesthesia—Betamethasone—psoriasis	0.000853	0.00086	CcSEcCtD
Methyldopa—Mental disorder—Methotrexate—psoriasis	0.000852	0.00086	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisolone—psoriasis	0.000838	0.000846	CcSEcCtD
Methyldopa—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000835	0.000842	CcSEcCtD
Methyldopa—Body temperature increased—Triamcinolone—psoriasis	0.000827	0.000834	CcSEcCtD
Methyldopa—Dizziness—Cyclosporine—psoriasis	0.000827	0.000834	CcSEcCtD
Methyldopa—Oedema—Prednisone—psoriasis	0.000827	0.000834	CcSEcCtD
Methyldopa—Infection—Prednisone—psoriasis	0.000822	0.000829	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Dexamethasone—psoriasis	0.00082	0.000827	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Betamethasone—psoriasis	0.00082	0.000827	CcSEcCtD
Methyldopa—Hypersensitivity—Hydrocortisone—psoriasis	0.000819	0.000826	CcSEcCtD
Methyldopa—Nervous system disorder—Prednisone—psoriasis	0.000811	0.000818	CcSEcCtD
Methyldopa—Dizziness—Mycophenolate mofetil—psoriasis	0.000807	0.000814	CcSEcCtD
Methyldopa—Skin disorder—Prednisone—psoriasis	0.000803	0.00081	CcSEcCtD
Methyldopa—Asthenia—Hydrocortisone—psoriasis	0.000797	0.000804	CcSEcCtD
Methyldopa—Vomiting—Cyclosporine—psoriasis	0.000795	0.000802	CcSEcCtD
Methyldopa—Rash—Cyclosporine—psoriasis	0.000789	0.000795	CcSEcCtD
Methyldopa—Dermatitis—Cyclosporine—psoriasis	0.000788	0.000795	CcSEcCtD
Methyldopa—Headache—Cyclosporine—psoriasis	0.000783	0.00079	CcSEcCtD
Methyldopa—Vomiting—Mycophenolate mofetil—psoriasis	0.000776	0.000782	CcSEcCtD
Methyldopa—Hypersensitivity—Triamcinolone—psoriasis	0.000771	0.000778	CcSEcCtD
Methyldopa—Rash—Mycophenolate mofetil—psoriasis	0.000769	0.000776	CcSEcCtD
Methyldopa—Dermatitis—Mycophenolate mofetil—psoriasis	0.000768	0.000775	CcSEcCtD
Methyldopa—Headache—Mycophenolate mofetil—psoriasis	0.000764	0.000771	CcSEcCtD
Methyldopa—Diarrhoea—Hydrocortisone—psoriasis	0.00076	0.000767	CcSEcCtD
Methyldopa—Leukopenia—Methotrexate—psoriasis	0.000758	0.000764	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Prednisone—psoriasis	0.000753	0.00076	CcSEcCtD
Methyldopa—Dizziness—Prednisolone—psoriasis	0.000753	0.000759	CcSEcCtD
Methyldopa—Asthenia—Triamcinolone—psoriasis	0.000751	0.000757	CcSEcCtD
Methyldopa—Body temperature increased—Dexamethasone—psoriasis	0.000751	0.000757	CcSEcCtD
Methyldopa—Body temperature increased—Betamethasone—psoriasis	0.000751	0.000757	CcSEcCtD
Methyldopa—Nausea—Cyclosporine—psoriasis	0.000743	0.000749	CcSEcCtD
Methyldopa—Paraesthesia—Prednisone—psoriasis	0.000743	0.000749	CcSEcCtD
Methyldopa—Dizziness—Hydrocortisone—psoriasis	0.000735	0.000741	CcSEcCtD
Methyldopa—Nausea—Mycophenolate mofetil—psoriasis	0.000725	0.000731	CcSEcCtD
Methyldopa—Myalgia—Methotrexate—psoriasis	0.000721	0.000727	CcSEcCtD
Methyldopa—Arthralgia—Methotrexate—psoriasis	0.000721	0.000727	CcSEcCtD
Methyldopa—Rash—Prednisolone—psoriasis	0.000718	0.000724	CcSEcCtD
Methyldopa—Dermatitis—Prednisolone—psoriasis	0.000717	0.000723	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000716	0.000722	CcSEcCtD
Methyldopa—Headache—Prednisolone—psoriasis	0.000713	0.000719	CcSEcCtD
Methyldopa—Constipation—Prednisone—psoriasis	0.000707	0.000713	CcSEcCtD
Methyldopa—Vomiting—Hydrocortisone—psoriasis	0.000707	0.000713	CcSEcCtD
Methyldopa—Rash—Hydrocortisone—psoriasis	0.000701	0.000707	CcSEcCtD
Methyldopa—Dermatitis—Hydrocortisone—psoriasis	0.0007	0.000706	CcSEcCtD
Methyldopa—Headache—Hydrocortisone—psoriasis	0.000696	0.000702	CcSEcCtD
Methyldopa—Dizziness—Triamcinolone—psoriasis	0.000692	0.000698	CcSEcCtD
Methyldopa—Infection—Methotrexate—psoriasis	0.000687	0.000692	CcSEcCtD
Methyldopa—Asthenia—Dexamethasone—psoriasis	0.000681	0.000687	CcSEcCtD
Methyldopa—Asthenia—Betamethasone—psoriasis	0.000681	0.000687	CcSEcCtD
Methyldopa—Nervous system disorder—Methotrexate—psoriasis	0.000678	0.000684	CcSEcCtD
Methyldopa—Thrombocytopenia—Methotrexate—psoriasis	0.000677	0.000682	CcSEcCtD
Methyldopa—Nausea—Prednisolone—psoriasis	0.000676	0.000682	CcSEcCtD
Methyldopa—Skin disorder—Methotrexate—psoriasis	0.000671	0.000677	CcSEcCtD
Methyldopa—Vomiting—Triamcinolone—psoriasis	0.000665	0.000671	CcSEcCtD
Methyldopa—Nausea—Hydrocortisone—psoriasis	0.00066	0.000666	CcSEcCtD
Methyldopa—Rash—Triamcinolone—psoriasis	0.00066	0.000666	CcSEcCtD
Methyldopa—Dermatitis—Triamcinolone—psoriasis	0.000659	0.000665	CcSEcCtD
Methyldopa—Headache—Triamcinolone—psoriasis	0.000656	0.000661	CcSEcCtD
Methyldopa—Body temperature increased—Prednisone—psoriasis	0.000654	0.000659	CcSEcCtD
Methyldopa—Diarrhoea—Dexamethasone—psoriasis	0.00065	0.000655	CcSEcCtD
Methyldopa—Diarrhoea—Betamethasone—psoriasis	0.00065	0.000655	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methotrexate—psoriasis	0.00063	0.000635	CcSEcCtD
Methyldopa—Dizziness—Betamethasone—psoriasis	0.000628	0.000633	CcSEcCtD
Methyldopa—Dizziness—Dexamethasone—psoriasis	0.000628	0.000633	CcSEcCtD
Methyldopa—Nausea—Triamcinolone—psoriasis	0.000622	0.000627	CcSEcCtD
Methyldopa—Paraesthesia—Methotrexate—psoriasis	0.000621	0.000626	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisone—psoriasis	0.000609	0.000614	CcSEcCtD
Methyldopa—Vomiting—Betamethasone—psoriasis	0.000604	0.000609	CcSEcCtD
Methyldopa—Vomiting—Dexamethasone—psoriasis	0.000604	0.000609	CcSEcCtD
Methyldopa—Rash—Betamethasone—psoriasis	0.000599	0.000604	CcSEcCtD
Methyldopa—Rash—Dexamethasone—psoriasis	0.000599	0.000604	CcSEcCtD
Methyldopa—Dermatitis—Betamethasone—psoriasis	0.000598	0.000603	CcSEcCtD
Methyldopa—Dermatitis—Dexamethasone—psoriasis	0.000598	0.000603	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Methotrexate—psoriasis	0.000597	0.000602	CcSEcCtD
Methyldopa—Headache—Dexamethasone—psoriasis	0.000595	0.0006	CcSEcCtD
Methyldopa—Headache—Betamethasone—psoriasis	0.000595	0.0006	CcSEcCtD
Methyldopa—Asthenia—Prednisone—psoriasis	0.000593	0.000598	CcSEcCtD
Methyldopa—Diarrhoea—Prednisone—psoriasis	0.000566	0.000571	CcSEcCtD
Methyldopa—Nausea—Dexamethasone—psoriasis	0.000564	0.000569	CcSEcCtD
Methyldopa—Nausea—Betamethasone—psoriasis	0.000564	0.000569	CcSEcCtD
Methyldopa—Dizziness—Prednisone—psoriasis	0.000547	0.000552	CcSEcCtD
Methyldopa—Body temperature increased—Methotrexate—psoriasis	0.000546	0.000551	CcSEcCtD
Methyldopa—Vomiting—Prednisone—psoriasis	0.000526	0.00053	CcSEcCtD
Methyldopa—Rash—Prednisone—psoriasis	0.000521	0.000526	CcSEcCtD
Methyldopa—Dermatitis—Prednisone—psoriasis	0.000521	0.000525	CcSEcCtD
Methyldopa—Headache—Prednisone—psoriasis	0.000518	0.000522	CcSEcCtD
Methyldopa—Hypersensitivity—Methotrexate—psoriasis	0.000509	0.000514	CcSEcCtD
Methyldopa—Asthenia—Methotrexate—psoriasis	0.000496	0.0005	CcSEcCtD
Methyldopa—Nausea—Prednisone—psoriasis	0.000491	0.000495	CcSEcCtD
Methyldopa—Diarrhoea—Methotrexate—psoriasis	0.000473	0.000477	CcSEcCtD
Methyldopa—Dizziness—Methotrexate—psoriasis	0.000457	0.000461	CcSEcCtD
Methyldopa—Vomiting—Methotrexate—psoriasis	0.000439	0.000443	CcSEcCtD
Methyldopa—Rash—Methotrexate—psoriasis	0.000436	0.000439	CcSEcCtD
Methyldopa—Dermatitis—Methotrexate—psoriasis	0.000435	0.000439	CcSEcCtD
Methyldopa—Headache—Methotrexate—psoriasis	0.000433	0.000437	CcSEcCtD
Methyldopa—Nausea—Methotrexate—psoriasis	0.000411	0.000414	CcSEcCtD
